Problem

LifestyleRx addresses the gap between the scale of Type 2 diabetes and the healthcare system’s capacity to provide sustained lifestyle support. Type 2 accounts for roughly 90–95% of diabetes cases, and Diabetes Canada estimates that 30% of Canadians live with diabetes or prediabetes. The economic burden is substantial: direct healthcare costs were estimated at $18.25 billion in 2024, while annual out-of-pocket costs for people with Type 2 diabetes can reach $10,014. Although lifestyle counselling is a recommended foundation of care, the company notes that it often does not fit within ordinary primary-care practices.

The main use case is a Canadian patient with Type 2 diabetes or prediabetes who needs practical, ongoing help lowering blood sugar and potentially reaching remission, but cannot obtain intensive lifestyle coaching through routine visits. LifestyleRx makes that intervention available virtually and, in British Columbia, Alberta, and Ontario, at no cost to patients with applicable provincial coverage, while providing clinical supervision for medication changes and coordination with the patient’s family doctor.

Product / Service

LifestyleRx is a physician-led virtual care program delivered through a 12-week course. Patients receive virtual physician visits, weekly group medical sessions, educational videos and lessons, exercises, and personal health reports. The groups generally contain 15–30 patients, allowing one physician-led program to support many people without requiring travel or waiting-room visits.

Its core clinical framework is the “4+2 Diabetes Reversal Strategy,” which focuses on six sustainable behaviours involving diet, sleep, light exercise, stress reduction, and related habits. The program emphasizes whole foods, gradual changes, and understanding why the changes matter rather than extreme dieting or calorie counting. Physicians review patients’ histories, laboratory results, and medications, can help reduce or eliminate medication when appropriate, and keep the primary-care provider informed. The result is a low-friction, remission-oriented form of lifestyle medicine rather than a standalone wellness app.

Market

LifestyleRx competes in virtual diabetes care, digital health, and lifestyle medicine, with a distinctive focus on physician-supervised Type 2 diabetes reversal and insurance-funded delivery. The closest documented alternatives are adjacent rather than identical: Yes Health has offered an all-mobile virtual diabetes-prevention program in Alberta, while Omada provides digital diabetes-management services, including a partnership involving continuous glucose monitoring. LifestyleRx’s differentiation is its physician-led group-care model, provincial coverage in Canada, and explicit emphasis on remission rather than only disease monitoring.

The company is not merely pre-launch. Its Y Combinator launch profile, which identifies LifestyleRx as founded in 2022 and active in Canada, reported 2,000 patients and 500 additional patients per month at the time, as well as 46% of patients reaching the A1C range associated with remission. It also announced a 2023 distribution partnership with LifeLabs, and a funding database reports a $500,000 2023 seed round from Y Combinator. Company provider materials separately report outcomes for 653 patients—91% improving A1C, 44% reaching below 6.5%, and a 1.38-point average A1C reduction—but do not establish that those figures are exclusively Canadian. Current revenue is not disclosed in the available evidence, so the company should not be classified as pre-revenue solely on that basis.